HROW
HARROW, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$29.05
+1.79%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$28.41
From 52W high−46.99%
Volume311396.00
Market cap$1.09B
P/E (TTM)—
P/S (TTM)4.0x
Div yield—
Key dataNov 4, 2026
Open
$28.41
From 52W high
−46.99%
Volume
311396.00
Market cap
$1.09B
ValuationView details →
P/E (Fwd)
17.4x
EV/EBITDA
116.7x
P/E (TTM)
—
RSI (14)
40.5
MomentumView details →
1D Return
+1.79%
YTD Return
−41.94%
SummaryUpdated Jun 1, 2026
Harrow Health, Inc. (NASDAQ:HROW) is a specialty pharmaceutical company focused on the ophthalmology market. Originally incorporated in 2006 as Imprimis Pharmaceuticals, the company rebranded to Harrow Health in December 2018 to reflect its broader healthcare focus. Based in San Diego, California, Harrow has evolved from a compounding pharmacy business into a diversified ophthalmic pharmaceutical company that develops, manufactures, and commercializes prescription drugs for eye care professionals and their patients across North America.
Similar companies
Latest newsMore news →